{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:55:35Z","timestamp":1791618935422,"version":"4.3.4"},"reference-count":59,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,3,22]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Proton pump inhibitors (PPIs) are widely used, and their use is associated with increased risk of adverse events. However, whether PPI use is associated with excess risk of death is unknown. We aimed to examine the association between PPI use and risk of all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Longitudinal observational cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>US Department of Veterans Affairs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Primary cohort of new users of PPI or histamine H2 receptor antagonists (H2 blockers) (n=349\u2009312); additional cohorts included PPI versus no PPI (n=3\u2009288\u2009092) and PPI versus no PPI and no H2 blockers (n=2\u2009887\u2009030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 5.71 years (IQR 5.11\u20136.37), PPI use was associated with increased risk of death compared with H2 blockers use (HR 1.25, CI 1.23 to 1.28). Risk of death associated with PPI use was higher in analyses adjusted for high-dimensional propensity score (HR 1.16, CI 1.13 to 1.18), in two-stage residual inclusion estimation (HR 1.21, CI 1.16 to 1.26) and in 1:1 time-dependent propensity score-matched cohort (HR 1.34, CI 1.29 to 1.39). The risk of death was increased when considering PPI use versus no PPI (HR 1.15, CI 1.14 to 1.15), and PPI use versus no PPI and no H2 blockers (HR 1.23, CI 1.22 to 1.24). Risk of death associated with PPI use was increased among participants without gastrointestinal conditions: PPI versus H2 blockers (HR 1.24, CI 1.21 to 1.27), PPI use versus no PPI (HR 1.19, CI 1.18 to 1.20) and PPI use versus no PPI and no H2 blockers (HR 1.22, CI 1.21 to 1.23). Among new PPI users, there was a graded association between the duration of exposure and the risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results suggest excess risk of death among PPI users; risk is also increased among those without gastrointestinal conditions and with prolonged duration of use. Limiting PPI use and duration to instances where it is medically indicated may be warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-015735","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T20:10:18Z","timestamp":1499199018000},"page":"e015735","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":206,"title":["Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans"],"prefix":"10.1136","volume":"7","author":[{"given":"Yan","family":"Xie","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bowe","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"},{"name":"Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xian","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"},{"name":"Department of Biostatistics, College for Public Health and Social Justice, Saint Louis University, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"},{"name":"Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-0434","authenticated-orcid":false,"given":"Ziyad","family":"Al-Aly","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"},{"name":"Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA"},{"name":"Renal Section, Medicine Service, VA Saint Louis Health Care System, Saint Louis, Missouri, USA"},{"name":"Institute for Public Health, Washington University in Saint Louis, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"2025121509244565000_7.6.e015735.1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.7927"},{"key":"2025121509244565000_7.6.e015735.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015121377"},{"key":"2025121509244565000_7.6.e015735.3","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140074"},{"key":"2025121509244565000_7.6.e015735.4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-150"},{"key":"2025121509244565000_7.6.e015735.5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.74"},{"key":"2025121509244565000_7.6.e015735.6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.7193"},{"key":"2025121509244565000_7.6.e015735.7","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"key":"2025121509244565000_7.6.e015735.8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025121509244565000_7.6.e015735.9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.452"},{"key":"2025121509244565000_7.6.e015735.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.05.012"},{"key":"2025121509244565000_7.6.e015735.11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-10-200911170-00016"},{"key":"2025121509244565000_7.6.e015735.12","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.108"},{"key":"2025121509244565000_7.6.e015735.13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"2025121509244565000_7.6.e015735.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.007"},{"key":"2025121509244565000_7.6.e015735.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.001177"},{"key":"2025121509244565000_7.6.e015735.16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304738"},{"key":"2025121509244565000_7.6.e015735.17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.092129"},{"key":"2025121509244565000_7.6.e015735.18","doi-asserted-by":"crossref","unstructured":"Yepuri G , Sukhovershin R , Nazari-Shafti TZ , et al . Proton pump inhibitors accelerate endothelial senescence. Circ Res 2016;118.doi:10.1161\/CIRCRESAHA.116.308807","DOI":"10.1161\/CIRCRESAHA.116.308807"},{"key":"2025121509244565000_7.6.e015735.19","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.304"},{"key":"2025121509244565000_7.6.e015735.20","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2851"},{"key":"2025121509244565000_7.6.e015735.21","doi-asserted-by":"crossref","first-page":"488.e9","DOI":"10.1016\/j.jamda.2012.03.003","article-title":"Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland","volume":"13","author":"Teramura-Gr\u00f6nblad","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"2025121509244565000_7.6.e015735.22","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.164"},{"key":"2025121509244565000_7.6.e015735.23","doi-asserted-by":"publisher","DOI":"10.2307\/2286902"},{"key":"2025121509244565000_7.6.e015735.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171377","article-title":"Serum phosphorus levels and risk of incident dementia","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"2025121509244565000_7.6.e015735.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2345-0"},{"key":"2025121509244565000_7.6.e015735.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.12.034"},{"key":"2025121509244565000_7.6.e015735.27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00730116"},{"key":"2025121509244565000_7.6.e015735.28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ekir.2016.08.016","article-title":"Geographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline","volume":"2","author":"Bowe","year":"2017","journal-title":"Kidney International Reports"},{"key":"2025121509244565000_7.6.e015735.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121509244565000_7.6.e015735.30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2016.02.039","article-title":"Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality","volume":"68","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2025121509244565000_7.6.e015735.31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04480415"},{"key":"2025121509244565000_7.6.e015735.32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2016.02.039","article-title":"Estimated GFR trajectories of people entering CKD Stage 4 and subsequent kidney disease outcomes and mortality","volume":"68","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2025121509244565000_7.6.e015735.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149283","article-title":"Renal function trajectories in patients with prior improved eGFR slopes and risk of death","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"2025121509244565000_7.6.e015735.34","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.124"},{"key":"2025121509244565000_7.6.e015735.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2005.00356.x"},{"key":"2025121509244565000_7.6.e015735.36","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq439"},{"key":"2025121509244565000_7.6.e015735.37","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181a663cc"},{"key":"2025121509244565000_7.6.e015735.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2007.09.009"},{"key":"2025121509244565000_7.6.e015735.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.01.004"},{"key":"2025121509244565000_7.6.e015735.40","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1357"},{"key":"2025121509244565000_7.6.e015735.41","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1200"},{"key":"2025121509244565000_7.6.e015735.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31679-8"},{"key":"2025121509244565000_7.6.e015735.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"2025121509244565000_7.6.e015735.44","first-page":"493","article-title":"Thomsen RW Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting","volume":"5","author":"Hvid-Jensen","year":"2013","journal-title":"Dovepress"},{"key":"2025121509244565000_7.6.e015735.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"2025121509244565000_7.6.e015735.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39406.449456.BE"},{"key":"2025121509244565000_7.6.e015735.47","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn035"},{"key":"2025121509244565000_7.6.e015735.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02454.x"},{"key":"2025121509244565000_7.6.e015735.49","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.570"},{"key":"2025121509244565000_7.6.e015735.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.892"},{"key":"2025121509244565000_7.6.e015735.51","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.64"},{"key":"2025121509244565000_7.6.e015735.52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamainternmed.2013.4068","article-title":"Reversing gears: discontinuing medication therapy to prevent adverse events","volume":"173","author":"Linsky","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025121509244565000_7.6.e015735.53","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.90"},{"key":"2025121509244565000_7.6.e015735.54","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.51"},{"key":"2025121509244565000_7.6.e015735.55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000094020","article-title":"Effect of proton pump inhibitors on hepatic regeneration","volume":"38","author":"Kucuk","year":"2006","journal-title":"Eur Surg Res"},{"key":"2025121509244565000_7.6.e015735.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.04.170"},{"key":"2025121509244565000_7.6.e015735.57","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000437613.88158.d3"},{"key":"2025121509244565000_7.6.e015735.58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/tx5003782","article-title":"Systematic toxicity mechanism analysis of proton pump inhibitors: an in\u00a0Silico Study","volume":"28","author":"Wu","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"2025121509244565000_7.6.e015735.59","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0774-5"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-015735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:24:53Z","timestamp":1765819493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-015735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,7,4]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjopen-2016-015735"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-015735","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}